Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E

C A O'Callaghan1, J Tormo, B E Willcox

  • 1Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, United Kingdom.

Molecular Cell
|July 14, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticholinergic drug use and risk of mortality for people with dementia in Northern Ireland.

Aging & mental health·2020
Same author

Association of cicatricial alopecia with chemical hair straightening.

The British journal of dermatology·2019
Same author

Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.

Oncogene·2017
Same author

Secondary structure and (1)H, (13)C and (15)N resonance assignments of Skint-1: a selecting ligand for a murine γδ T cell subset implicated in tumour suppression.

Biomolecular NMR assignments·2016
Same author

Pseudofolliculitis barbae: understanding the condition and the role of facial grooming.

International journal of cosmetic science·2016
Same author

Setting environmental exposure standards: Current concepts and controversies.

International journal of environmental health research·2016

The crystal structure of human HLA-E reveals it binds specific peptides from MHC class I leader sequences. This structure acts as a checkpoint for natural killer cells, ensuring antigen processing pathway integrity.

Area of Science:

  • Immunology
  • Structural Biology
  • Molecular Biology

Background:

  • The human leukocyte antigen E (HLA-E) is a nonclassical MHC class Ib molecule.
  • HLA-E plays a crucial role in immune surveillance by interacting with natural killer (NK) cells.

Purpose of the Study:

  • To determine the crystal structure of HLA-E in complex with a prototypic ligand.
  • To understand the molecular basis of HLA-E's peptide binding specificity and its implications for immune recognition.

Main Methods:

  • X-ray crystallography was used to determine the high-resolution crystal structure of the HLA-E/peptide complex.
  • The prototypic ligand was a nonamer peptide (VMAPRTVLL) derived from the conserved MHC class Ia leader sequence.

Main Results:

Related Experiment Videos

  • The crystal structure revealed conserved and novel features in the peptide-binding mode of HLA-E.
  • Novel features suggest HLA-E specifically binds a defined set of hydrophobic peptides from conserved class I leader sequences.
  • These adaptations position HLA-E as a critical checkpoint for antigen processing pathway integrity.

Conclusions:

  • HLA-E has evolved specific molecular adaptations for binding conserved leader peptides.
  • These adaptations enable HLA-E to function as a cellular checkpoint, reporting pathway integrity to CD94/NKG2 receptor-bearing NK cells.
  • The findings provide insights into the molecular mechanisms of immune regulation mediated by HLA-E.